Clinical practices in feline chronic kidney disease: A cross-sectional study of primary care veterinarians in Turkey

Feline chronic kidney disease (CKD) is a common condition in cats. International guideline adherence may vary among veterinary practitioners. The objective of the study is to evaluate the diagnostic, therapeutic and monitoring practices of primary care veterinarians in Turkey regarding feline CKD and to compare these practices with guidelines. A cross-sectional online questionnaire consisting of 32 items was distributed to veterinarians. The survey addressed demographics, diagnostic approaches, treatment modalities and monitoring strategies for feline CKD cases. Descriptive statistics were calculated to analyse responses. A total of 281 veterinarians participated. While 93.6% were aware of IRIS guidelines, only 55.2% reported performing all recommended diagnostic procedures. SDMA was used alongside creatinine by 73.6% of respondents. However, only 30.5% routinely measured blood pressure. Telmisartan and ACE inhibitors were commonly used, but amlodipine was prescribed by only 8.9%. Most veterinarians recommended renal diets irrespective of CKD stage and typically suggested a short 1–2 week transition period. Follow-up intervals varied, with 40.9% recommending re-evaluations every 2–3 months. Although awareness of international guidelines is high, discrepancies remain in disease substaging, blood pressure monitoring and antihypertensive drug selection. Greater emphasis on blood pressure measurement and improved access to feline-licensed drugs may enhance CKD management in cats.